About us

Eurosurveillance is a European peer-reviewed scientific journal devoted to the epidemiology, surveillance, prevention and control of communicable diseases, with a focus on such topics that are of relevance to Europe. It is a weekly online journal, with 50 issues per year published on Thursdays, and features short rapid communications, longer in-depth research articles, surveillance and outbreak reports, reviews and perspective papers, as well as short news items. Timely publication of short authoritative papers on ongoing outbreaks or other relevant public health events is one of the major assets of the journal. Under special circumstances when current events need to be urgently communicated to readers for rapid public health action, e-alerts can be released outside of the regular publishing schedule. Topical compilations of selected articles and special issues are also published in print with a limited number of copies.

Metrics

The journal has been selected for coverage by Thomson Reuters and is indexed and abstracted in the Science Citation Index Expanded and in the Journal Citation Reports/Science Edition beginning with volume 14(1) 2009. The most recent impact factor, for the year 2017, is 7.1 (Journal Citation Reports, Thomson Reuters, 2018). This places Eurosurveillance at rank 5 among the 88 journals in the category Infectious Diseases. The Scopus-based SCImago Journal Rank (SJR) for 2017 ranks Eurosurveillance 58 of 2,863 journals in the category Medicine (miscellaneous). The journal is also in the first quarter (Q1) in the categories Epidemiology, Public Health, Environmental and Occupational Health and Virology. Google Scholar metrics in 2017 listed Eurosurveillance at ranks 5 and 13 among journals in the categories Epidemiology and Communicable Diseases, respectively.

In 2017, 69 peer-reviewed rapid communications and 118 peer-reviewed regular articles were published in Eurosurveillance, by authors from ca 60 countries worldwide, as well as 20 editorials, letters and meeting reports. The acceptance rate was 21%. All articles since 1995 are available on the Eurosurveillance website.

Funding

Eurosurveillance was founded in 1995 when a first pilot issue was published. The journal was jointly funded until March 2007 by the European Commission, the Institut de Veille Sanitaire (InVS, now Santé publique France) in Paris, France and the Health Protection Agency (HPA, now Public Health England) in London, United Kingdom. Eurosurveillance is a registered trademark of the European Union (EU).

Since March 2007, Eurosurveillance has been published by the European Centre for Disease Prevention and Control (ECDC) in Stockholm, Sweden. ECDC funds this journal with its own resources; Eurosurveillance does not have any other sources of funding.

The
publisher grants editorial independence to
the editorial team. The views expressed in the journal are those of the authors
and may not necessarily comply with ECDC policy. As a non-profit publication,
the journal has no financial conflicts of interest.

HON certification

In January 2010, Eurosurveillance was accredited by the Health on the Net (HON) Foundation as adhering to the HON code of conduct (HONcode). HON is a non-governmental, non-profit organisation with the purpose of supporting users to identify sound, reliable and trustworthy health information on the Internet since 1995.